Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shenhong Wu

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 11, 2011
Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy-A meta-analysisAmna Sher, Shenhong Wu
Current Oncology Reports|April 4, 2018
Current and Emerging Therapeutic Targets for Metastatic Renal Cell CarcinomaKevin Zarrabi, Shenhong Wu
Clinical Hypertension|May 15, 2022
Risks and management of hypertension in cancer patients undergoing targeted therapy: a reviewXiaolei Zhu, Shenhong Wu
Cancer Investigation|September 27, 2019
Increased Risk of Hypertension with Enzalutamide in Prostate Cancer: A Meta-AnalysisXiaolei Zhu, Shenhong Wu
Translational Cancer Research|February 4, 2022
Avelumab plus axitinib <i>vs</i>. sunitinib for advanced renal-cell carcinomaYue Zhang, Shenhong Wu
Oncology|March 15, 2018
Risk of Liver Toxicity with Nivolumab Immunotherapy in Cancer PatientsKevin Zarrabi, Shenhong Wu
Expert Opinion on Biological Therapy|May 22, 2018
An evaluation of nivolumab for the treatment of metastatic renal cell carcinomaKevin Zarrabi, Shenhong Wu
Journal of Hematology & Oncology|August 13, 2008
Novel therapies in genitourinary cancer: an updateDavid Chu, Shenhong Wu
Clinical Hypertension|June 7, 2019
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysisXiaolei Zhu, Shenhong Wu
World Journal of Gastrointestinal Oncology|November 25, 2015
Novel therapy for advanced gastric cancerYue Zhang, Shenhong Wu
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Acta Oncologica (Stockholm, Sweden)|May 11, 2011
Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy-A meta-analysisAmna Sher, Shenhong Wu
Current Oncology Reports|April 4, 2018
Current and Emerging Therapeutic Targets for Metastatic Renal Cell CarcinomaKevin Zarrabi, Shenhong Wu
Clinical Hypertension|May 15, 2022
Risks and management of hypertension in cancer patients undergoing targeted therapy: a reviewXiaolei Zhu, Shenhong Wu
Cancer Investigation|September 27, 2019
Increased Risk of Hypertension with Enzalutamide in Prostate Cancer: A Meta-AnalysisXiaolei Zhu, Shenhong Wu
Translational Cancer Research|February 4, 2022
Avelumab plus axitinib <i>vs</i>. sunitinib for advanced renal-cell carcinomaYue Zhang, Shenhong Wu
Oncology|March 15, 2018
Risk of Liver Toxicity with Nivolumab Immunotherapy in Cancer PatientsKevin Zarrabi, Shenhong Wu
Expert Opinion on Biological Therapy|May 22, 2018
An evaluation of nivolumab for the treatment of metastatic renal cell carcinomaKevin Zarrabi, Shenhong Wu
Journal of Hematology & Oncology|August 13, 2008
Novel therapies in genitourinary cancer: an updateDavid Chu, Shenhong Wu
Clinical Hypertension|June 7, 2019
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysisXiaolei Zhu, Shenhong Wu
World Journal of Gastrointestinal Oncology|November 25, 2015
Novel therapy for advanced gastric cancerYue Zhang, Shenhong Wu
Pageof 8